⌘K

Login Start Free

Home/Filings/4/0000899243-21-003868

4//SEC Filing

Vavricka John 4

Accession 0000899243-21-003868

CIK 0001593899other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:51 PM ET

Size

5.3 KB

Accession

0000899243-21-003868

Insider Transaction Report

Form 4

Period: 2021-01-29

Atea Pharmaceuticals, Inc.AVIR

Chief Commercial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-01-29+117,300→ 117,300 total
Exercise: $73.00Exp: 2031-01-28→ Common Stock (117,300 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atea Pharmaceuticals, Inc.

CIK 0001593899

Entity typeother

Related Parties

1

filerCIK 0001829630

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 4:51 PM ET
Size: 5.3 KB

View on SEC.gov